Winningham Rick E sold TBPH

September 23, 2026 · Form 4 insider transaction

Winningham Rick E sold 76,875 shares of Theravance Biopharma Inc, a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
76,875
Price
N/A
Total value
N/A
RoleOfficer, Director
SecurityOrdinary Shares
Transaction codeD: Disposition to the issuer
Transaction dateSeptember 23, 2026
Filing dateSeptember 24, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

As of immediately prior to the Effective Time, each award of performance restricted stock units of the Issuer (a "Company PSU Award") that was outstanding as of immediately prior to the Effective Time was cancelled in exchange for the right to receive an amount in cash, without interest, equal to (i) the Per Share Cash Consideration multiplied by (ii) the number of Ordinary Shares with respect to such Company PSU Award that remained outstanding and unreleased as of immediately prior to the Effective Time, plus (iii) one CVR for each Ordinary Share underlying such Company PSU Award.

View the original Form 4 on SEC EDGAR